The administration of HSD, either concurrently or post-DMH exposure, significantly enhanced the expression of Smad4 and activin A while restoring antioxidant levels, thereby suggesting that HSD has the potential to attenuate CRC progression by bolstering antioxidant defenses and modulating tumor-suppressive signaling pathways (15). Here, SMAD4 is linked to colorectal carcinoma.